Industry Donates Big This Election

Biotech, pharmaceutical, and insurance companies have spent a record-breaking amount this election—nearly $200 million.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Wikimedia, comedy_noseThe health sector has spent more than $193 million this election cycle—topping its previous record, set during the 2008 election, by 9 percent, according to the Center for Responsive Politics, a non-partisan organization that analyses campaign spending.

The record-breaking donations were made possible by the 2010 Supreme Court ruling that eased restrictions on political contributions by businesses. As a result, corporations and large companies were able to spend more freely during the current political campaigns. “You have to make sure your point of view is represented,” Peter Kezirian of the Cooperative of American Physicians, told Nature. His organization seeks to influence medical malpractice reform and has spent roughly $2.1 million this election.

Some experts say that the process raises serious ethical concerns, allowing big business to influence the decisions of their candidate of choice. “We have an inherent trust in health-care providers, but we have to understand that they are part of a larger system,” Judy Nadler, an expert in government ethics ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies